• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌基因 FOXM1a 异构体是口腔鳞状细胞癌中受 hnRNP C 抑制的肿瘤抑制因子。

FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.

机构信息

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.

Department of Oral and Maxillofacial Surgery, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.

出版信息

Biomolecules. 2023 Aug 30;13(9):1331. doi: 10.3390/biom13091331.

DOI:10.3390/biom13091331
PMID:37759731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10526205/
Abstract

FOXM1 is an oncogenic transcriptional factor and includes several isoforms generated by alternative splicing. Inclusion of alternative exon 9 produces FOXM1a, a transcriptionally inactive isoform. However, the role of FOXM1a in tumorigenesis remains unknown. In addition, the regulatory mechanisms of exon 9 splicing are also unclear. In the present study, we found that overexpression of FOXM1a significantly reduced cell proliferation and colony formation of oral squamous cell carcinoma (OSCC) cell proliferation in vitro. Importantly, OSCC cells with FOXM1a overexpression showed significantly slower tumor formation in nude mice. Moreover, we identified a U-rich exonic splicing suppressor (ESS) which is responsible for exon 9 skipping. Splicing factor heterogeneous nuclear ribonucleoprotein C (hnRNP C) can bind to the ESS and suppress exon 9 inclusion and FOXM1a expression. Silence of hnRNP C also significantly suppresses OSCC cell proliferation. HnRNP C is significantly co-expressed with FOXM1 in cancers. Our study uncovered a novel regulatory mechanism of oncogene FOXM1 expression in OSCC.

摘要

FOXM1 是一种致癌转录因子,包括几个通过选择性剪接产生的异构体。内含子 9 的选择性剪接产生 FOXM1a,这是一种转录失活的异构体。然而,FOXM1a 在肿瘤发生中的作用尚不清楚。此外,exon 9 剪接的调节机制也不清楚。在本研究中,我们发现 FOXM1a 的过表达显著降低了口腔鳞状细胞癌(OSCC)细胞系体外的增殖和集落形成能力。重要的是,FOXM1a 过表达的 OSCC 细胞在裸鼠中形成肿瘤的速度明显较慢。此外,我们鉴定了一个富含 U 的外显子剪接抑制物(ESS),它负责 exon 9 的跳跃。异质核核糖核蛋白 C(hnRNP C)可以与 ESS 结合,抑制 exon 9 的内含和 FOXM1a 的表达。hnRNP C 的沉默也显著抑制了 OSCC 细胞的增殖。hnRNP C 在癌症中与 FOXM1 显著共表达。我们的研究揭示了 OSCC 中致癌基因 FOXM1 表达的一种新的调节机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/833452d110da/biomolecules-13-01331-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/68714b8edfb8/biomolecules-13-01331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/d2f10e8ab426/biomolecules-13-01331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/263b2a327fff/biomolecules-13-01331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/2e313db8558c/biomolecules-13-01331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/74c97ef2db4b/biomolecules-13-01331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/833452d110da/biomolecules-13-01331-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/68714b8edfb8/biomolecules-13-01331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/d2f10e8ab426/biomolecules-13-01331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/263b2a327fff/biomolecules-13-01331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/2e313db8558c/biomolecules-13-01331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/74c97ef2db4b/biomolecules-13-01331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/10526205/833452d110da/biomolecules-13-01331-g006.jpg

相似文献

1
FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.癌基因 FOXM1a 异构体是口腔鳞状细胞癌中受 hnRNP C 抑制的肿瘤抑制因子。
Biomolecules. 2023 Aug 30;13(9):1331. doi: 10.3390/biom13091331.
2
Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.hnRNP L 外显子 7 的包含与头颈部鳞状细胞癌的良好预后相关,并受癌基因 SRSF3 抑制。
Biomed Res Int. 2019 Nov 13;2019:9612425. doi: 10.1155/2019/9612425. eCollection 2019.
3
HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.hnRNP L 对致癌基因 SRSF3 的表达和口腔鳞状细胞癌细胞的致癌潜能很重要。
Sci Rep. 2016 Nov 3;6:35976. doi: 10.1038/srep35976.
4
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.FOXM1 介导的活性氧调节与口腔鳞状细胞癌细胞的放射抵抗性。
Lab Invest. 2023 May;103(5):100060. doi: 10.1016/j.labinv.2022.100060. Epub 2023 Jan 10.
5
HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.异质性核糖核蛋白C、YB-1和异质性核糖核蛋白L协同增强人肌肉特异性激酶(MUSK)外显子10的跳跃,以产生一种对Wnt不敏感的MUSK异构体。
Sci Rep. 2014 Oct 30;4:6841. doi: 10.1038/srep06841.
6
Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.视黄酸诱导人口腔鳞状细胞癌(OSCC)细胞中 FOXO3A 和 FOXM1 转录因子之间的拮抗作用。
PLoS One. 2019 Apr 12;14(4):e0215234. doi: 10.1371/journal.pone.0215234. eCollection 2019.
7
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.口腔鳞状细胞癌中预后性可变剪接标志的鉴定。
J Cell Physiol. 2020 May;235(5):4804-4813. doi: 10.1002/jcp.29357. Epub 2019 Oct 21.
8
HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.HNRNPC 通过 FOXM1 的 m6A 依赖性可变剪接介导宫颈癌的淋巴转移。
Cell Death Dis. 2024 Oct 7;15(10):732. doi: 10.1038/s41419-024-07108-4.
9
Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.功能获得性突变 p53 通过靶向转录因子 FOXO3a 和 FOXM1 促进头颈部鳞状细胞癌细胞的致癌潜能。
Oncogene. 2018 Mar;37(10):1279-1292. doi: 10.1038/s41388-017-0032-z. Epub 2017 Dec 22.
10
Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).鉴定 RNA 剪接因子 Lsm12 为口腔鳞状细胞癌(OSCC)中的一种新型肿瘤相关基因和有效生物标志物。
J Exp Clin Cancer Res. 2022 Apr 21;41(1):150. doi: 10.1186/s13046-022-02355-9.

引用本文的文献

1
HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.HNRNPC 通过 FOXM1 的 m6A 依赖性可变剪接介导宫颈癌的淋巴转移。
Cell Death Dis. 2024 Oct 7;15(10):732. doi: 10.1038/s41419-024-07108-4.
2
Alternative Splicing of Pre-mRNA Matters in Oral Diseases.前体mRNA的可变剪接在口腔疾病中至关重要。
Curr Gene Ther. 2025;25(4):349-359. doi: 10.2174/0115665232302948240718050212.

本文引用的文献

1
Alternative mRNA Splicing and Promising Therapies in Cancer.癌症中的替代性 mRNA 剪接和有前途的治疗方法。
Biomolecules. 2023 Mar 20;13(3):561. doi: 10.3390/biom13030561.
2
FOXM1: A small fox that makes more tracks for cancer progression and metastasis.FOXM1:一个制造更多癌症进展和转移轨迹的小狐狸。
Semin Cancer Biol. 2023 Jul;92:1-15. doi: 10.1016/j.semcancer.2023.03.007. Epub 2023 Mar 22.
3
Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
HNRNPK通过促进组蛋白编码阅读器SPIN1外显子4的包含对癌细胞增殖和细胞周期进程进行表观遗传控制。
J Mol Biol. 2023 Mar 15;435(6):167993. doi: 10.1016/j.jmb.2023.167993. Epub 2023 Feb 2.
4
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.FOXM1 抑制通过调节 PD-L1 表达和细胞增殖增强肺癌免疫治疗的疗效。
Adv Sci (Weinh). 2022 Oct;9(29):e2202702. doi: 10.1002/advs.202202702. Epub 2022 Aug 17.
5
lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma.长链非编码 RNA CYTOR 通过 HNRNPC 介导的 ZEB1 稳定促进口腔鳞状细胞癌中的异常糖酵解和线粒体呼吸。
Cell Death Dis. 2022 Aug 13;13(8):703. doi: 10.1038/s41419-022-05157-1.
6
FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non-Small Cell Lung Cancer.FOXM1变异体通过激活非小细胞肺癌患者的Wnt/β-连环蛋白信号通路导致吉非替尼耐药。
Clin Cancer Res. 2022 Sep 1;28(17):3770-3784. doi: 10.1158/1078-0432.CCR-22-0791.
7
Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment.可变剪接的治疗靶向:癌症治疗的新前沿
Front Oncol. 2022 Apr 8;12:868664. doi: 10.3389/fonc.2022.868664. eCollection 2022.
8
Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).鉴定 RNA 剪接因子 Lsm12 为口腔鳞状细胞癌(OSCC)中的一种新型肿瘤相关基因和有效生物标志物。
J Exp Clin Cancer Res. 2022 Apr 21;41(1):150. doi: 10.1186/s13046-022-02355-9.
9
An analysis of the role of HnRNP C dysregulation in cancers.HnRNP C失调在癌症中的作用分析
Biomark Res. 2022 Apr 8;10(1):19. doi: 10.1186/s40364-022-00366-4.
10
A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis.新型 HIF1α-STIL-FOXM1 轴调控肿瘤转移。
J Biomed Sci. 2022 Apr 1;29(1):24. doi: 10.1186/s12929-022-00807-0.